Clinical Trial 40208

Garden Grove, CA 92845

Study Summary:

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult Patients with Schizophrenia

Qualified Participants Must:

• The patient has a diagnosis of schizophrenia
• The patient is a male or female of any ethnic origin, 18 through 65 years of age

Qualified Participants May Receive:

Compensation for time and travel 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.